Pathway-Centric Structure-Based Multi-Target Compound Screening for Anti-Virulence Drug Repurposing

International Journal of Molecular Sciences - Switzerland
doi 10.3390/ijms20143504
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Off-Target Based Drug Repurposing Opportunities for Tivantinib in Acute Myeloid Leukemia

Scientific Reports
Multidisciplinary
2019English

Repurposing Diabetes Drugs for Neurodegenerative Diseases: Anti-Diabetic Drug Reposition

International Research Journal Of Pharmacy
2019English

Construction of an miRNA-regulated Drug-Pathway Network Reveals Drug Repurposing Candidates for Myasthenia Gravis

International Journal of Molecular Medicine
MedicineGenetics
2017English

Versatile Pathway-Centric Approach Based on High-Throughput Sequencing to Anticancer Drug Discovery

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2012English

Computational Target-Based Drug Repurposing of Elbasvir, an Antiviral Drug Predicted to Bind Multiple SARS-CoV-2 Proteins

2020English

Structure-Based Functional Design of Drugs: From Target to Lead Compound

Methods in Molecular Biology
GeneticsMolecular Biology
2011English

A Novel Multi-Modal Drug Repurposing Approach for Identification of Potent Ack1 Inhibitors

2012English

Drug Repurposing for Gastrointestinal Stromal Tumor

Molecular Cancer Therapeutics
Cancer ResearchOncology
2013English

Sterol Biosynthesis Pathway as Target for Anti-Trypanosomatid Drugs

Interdisciplinary Perspectives on Infectious Diseases
VirologyParasitologyInfectious DiseasesMicrobiology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy